Robert F. Kennedy Jr. has vowed to combat "the chronic disease epidemic in this country" in the Trump administration, with ...

Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ETCompany ParticipantsBill Anderson - Chairman & CEOWolfgang Nickl ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

In September 2024, the Company presented multiple data analyses at Sleep Europe 2024, including results from the SYMPHONY ...

For example, for complex issues ... of inquiries is largely driven by FDA's webpages, which generate over 1 million hits each day. From 2000 to 2007, the number of e-mail requests sent to DDI ...

With its ability to improve neuron health, experimental drug NU-9 has already shown promise in reversing amyotrophic lateral ...

I'm pleased to share that the FDA recently granted breakthrough therapy designation ... and we expect to see growing momentum into 2025 and beyond. Livdelzi brings the number of innovative therapies ...

Nplate from Amgen is an example of a very ... committee unless the FDA determines otherwise, both Hay and Schmidt expect to see a continued increase in the number of advisory panels.

Operator: Ladies and gentlemen, welcome to Cassava Sciences Report for the Third Quarter 2024. At this time, all participants are in a listen-only mode.